Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-13 09:04 am Sale | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | Matrix Capital Management Company LP | 226,089,090 14.730% | -7,756,020 (-3.32%) | View |
| 2024-04-02 8:38 pm Unchanged | 13D | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | New Enterprise Associates 14 L.P. | 102,478,672 6.700% | 0 (Unchanged) | View |
| 2024-03-26 11:59 am Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | EcoR1 Capital LLC | 164,424,420 10.700% | 51,000,000 (+44.96%) | View |
| 2024-02-14 5:04 pm Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | Long Focus Capital Management LLC | 12,086,915 5.300% | 774,568 (+6.85%) | View |
| 2024-02-14 4:21 pm Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | BAKER BROS. ADVISORS LP | 65,815,692 4.800% | 6,830,430 (+11.58%) | View |
| 2024-01-30 5:26 pm Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | EcoR1 Capital LLC | 113,424,420 7.700% | 113,424,420 (New Position) | View |
| 2024-01-29 11:52 am Sale | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | BAILLIE GIFFORD & CO | 95,472,840 7.010% | -7,546,794 (-7.33%) | View |
| 2023-11-08 12:59 pm Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | Long Focus Capital Management LLC | 11,312,347 5.000% | 11,312,347 (New Position) | View |
| 2023-07-10 4:15 pm Unchanged | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | Matrix Capital Management Company LP | 233,845,110 17.290% | 0 (Unchanged) | View |
| 2023-03-30 5:13 pm Purchase | 13D | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | New Enterprise Associates 14 L.P. | 102,478,672 10.300% | 3,556,804 (+3.60%) | View |
| 2023-02-14 4:06 pm Sale | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | PFM Health Sciences LP | 29,061,060 3.000% | -25,597,620 (-46.83%) | View |
| 2023-02-13 2:49 pm Sale | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | Capital World Investors | 0 0.000% | -48,016,200 (Position Closed) | View |
| 2023-01-18 06:41 am Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | BAILLIE GIFFORD & CO | 103,019,634 10.480% | 401,082 (+0.39%) | View |
| 2022-12-02 07:33 am Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | BAILLIE GIFFORD & CO | 102,618,552 10.440% | 20,080,440 (+24.33%) | View |
| 2022-05-09 4:51 pm Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | PFM Health Sciences LP | 54,658,680 5.800% | 54,658,680 (New Position) | View |
| 2022-01-18 07:02 am Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | BAILLIE GIFFORD & CO | 82,538,112 8.810% | 20,391,432 (+32.81%) | View |
| 2021-02-16 4:08 pm Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | BAKER BROS. ADVISORS LP | 58,985,262 6.400% | 58,985,262 (New Position) | View |
| 2021-02-16 11:42 am Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | Capital World Investors | 48,016,200 5.200% | 48,016,200 (New Position) | View |
| 2021-02-16 10:03 am Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | Matrix Capital Management Company LP | 233,845,110 25.180% | 65,845,110 (+39.19%) | View |
| 2021-01-28 06:36 am Purchase | 13G | ADAPTIMMUNE THERAPEUTICS PLC S ADAP | BAILLIE GIFFORD & CO | 62,146,680 6.690% | 62,146,680 (New Position) | View |